Venrock Healthcare Capital Partners III, L.P.

Average Profitability
64.5%
Insider Buys Quantity
27
Insider Buys Sum
$38.82M
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Venrock Healthcare Capital Partners III, L.P.

According to the SEC Form 4 filings, Venrock Healthcare Capital Partners III, L.P., being in a position of

  1. 10 percent owner at KalVista Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 1251017 shares for $16.11M, and sold 0 shares,
    over all time since 2023-12-27, has bought 1251017 shares for $16.11M, and sold 0 shares.

The largest purchase of all time was on 2020-06-15 and amounted to 1500000 shares of Altimmune, Inc. for $11.31M.

Biography of Venrock Healthcare Capital Partners III, L.P.

No biography is available at this moment.

2024-02-08PurchaseKalVista Pharmaceuticals, Inc.
KALV
10 percent owner
29,747
0.0851%
$14.70$437,281-19.19%
2024-02-07PurchaseKalVista Pharmaceuticals, Inc.
KALV
10 percent owner
51,827
0.1468%
$14.56$754,601-16.61%
2024-02-06PurchaseKalVista Pharmaceuticals, Inc.
KALV
10 percent owner
4,474
0.0128%
$14.74$65,947-18.68%
2024-01-30PurchaseKalVista Pharmaceuticals, Inc.
KALV
10 percent owner
88,099
0.248%
$14.47$1.27M-18.67%
2024-01-29PurchaseKalVista Pharmaceuticals, Inc.
KALV
10 percent owner
80,600
0.2322%
$14.22$1.15M-15.77%
2024-01-26PurchaseKalVista Pharmaceuticals, Inc.
KALV
10 percent owner
4,174
0.0117%
$12.98$54,179-9.45%
2024-01-25PurchaseKalVista Pharmaceuticals, Inc.
KALV
10 percent owner
7,030
0.0202%
$12.73$89,492-5.36%
2024-01-24PurchaseKalVista Pharmaceuticals, Inc.
KALV
10 percent owner
20,686
0.0609%
$12.44$257,334-1.27%
2024-01-23PurchaseKalVista Pharmaceuticals, Inc.
KALV
10 percent owner
10,897
0.0314%
$12.54$136,648-3.97%
2024-01-22PurchaseKalVista Pharmaceuticals, Inc.
KALV
10 percent owner
67,546
0.189%
$12.55$847,702-6.42%
2024-01-19PurchaseKalVista Pharmaceuticals, Inc.
KALV
10 percent owner
25,000
0.0725%
$12.43$310,750-2.34%
2024-01-18PurchaseKalVista Pharmaceuticals, Inc.
KALV
10 percent owner
39,680
0.1152%
$12.51$496,397-2.93%
2024-01-17PurchaseKalVista Pharmaceuticals, Inc.
KALV
10 percent owner
78,925
0.2215%
$12.60$994,455-6.49%
2024-01-16PurchaseKalVista Pharmaceuticals, Inc.
KALV
10 percent owner
19,599
0.0564%
$12.73$249,495-4.98%
2024-01-11PurchaseKalVista Pharmaceuticals, Inc.
KALV
10 percent owner
6,647
0.0186%
$12.68$84,284-7.19%
2024-01-10PurchaseKalVista Pharmaceuticals, Inc.
KALV
10 percent owner
47,700
0.1389%
$12.67$604,359-3.42%
2024-01-09PurchaseKalVista Pharmaceuticals, Inc.
KALV
10 percent owner
20,816
0.0591%
$12.56$261,449-5.08%
2024-01-08PurchaseKalVista Pharmaceuticals, Inc.
KALV
10 percent owner
69,184
0.1919%
$12.44$860,649-6.47%
2024-01-04PurchaseKalVista Pharmaceuticals, Inc.
KALV
10 percent owner
41,764
0.1247%
$12.11$505,762+3.23%
2024-01-03PurchaseKalVista Pharmaceuticals, Inc.
KALV
10 percent owner
17,605
0.0511%
$12.20$214,781-0.49%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.